Dr. Cunningham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
Dept Of Pathology
Kansas City, KS 66160Phone+1 913-588-7070Fax+1 913-588-7073
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Hematopathology, 1993 - 1994
- University of Iowa Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 1989 - 1993
- University of Minnesota Medical SchoolClass of 1989
Certifications & Licensure
- KS State Medical License 1999 - 2025
- MO State Medical License 2013 - 2021
- American Board of Pathology Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Clinical Utility of Recently Food and Drug Administration-Approved IntelliSep Test (Sepsis Biomarker) for Early Diagnosis of Sepsis: Comparison with Other Biomarkers.Nima Sarani, Amitava Dasgupta, Maria Enders, Lauren Rowan, Hanan Elsarraj
Journal of Clinical Medicine. 2024-08-16 - Anaplastic Multiple Myeloma With a Novel Proliferation of Pleomorphic Binuclear Plasma Cells.Mark T Cunningham, Daniel Farrell, Sayedamin Mostofizadeh, Saurav Chopra
Cureus. 2024-07-01 - Burkitt Lymphoma With Aberrant Expression of Cytoplasmic Terminal Deoxynucleotidyl Transferase: A Case Report.Mark T Cunningham, Carmen Winters, Daniel Farrell
Cureus. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: